NCT03096340
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03096340
Title Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Intezyne Technologies, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mary Crowley Cancer Research Centers - Medical City Dallas Texas 75230 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field